Table 1.
Baseline demographics and clinical characteristics of the overall population.
| Overall population (n = 1529) | |
|---|---|
| Age, years, median (IQI) | 65 (61, 68) |
| BMIa, median (IQI) | 28.6 (25.5, 32.5) |
| Male, n (%) | 1475 (96.4) |
| Caucasian, n (%) | 1441 (94.4) |
| DMa, n (%) | 440 (28.8) |
| Hypertension, n (%) | 949 (62.0) |
| Hyperlipidemia, n (%) | 1147 (75.0) |
| Total cholesterol, median (IQI) | 176 (153, 204) |
| HDLa cholesterol, median (IQI) | 43 (36, 52) |
| Statin use, n (%) | 914 (59.7) |
| Current smoker, n (%) | 819 (53.6) |
| Family history of early CADa, n (%) | 192 (12.5) |
| CADa, n (%) | 366 (23.9) |
| Prior MIa, n (%) | 158 (10.3) |
| Prior CABGa, n (%) | 67 (4.3) |
| Prior CVAa, n (%) | 98 (6.4) |
| CKDa, n (%) | 221 (14.5) |
| GFRa, median (IQI) | 79.9 (69.3, 92.4) |
| ASCVDa Risk Score, median (IQI) | 18.9 (12.6, 28.4) |
| CACSa, median (IQI) | 546 (109, 1585) |
| AVCa, median (IQI) | 66 (0, 352) |
| All-cause mortality, n (%) | 227 (14.8) |
| MIa, n (%) | 112 (7.3) |
| CVAa, n (%) | 52 (3.4) |
a
AVC = aortic valve calcium score; ASCVD = atherosclerotic cardiovascular disease; BMI = body mass index; CABG = coronary artery bypass graft surgery; CACS = coronary artery calcium score; CAD = coronary artery disease; CKD = chronic kidney disease; CVA = cerebrovascular accident; DM = diabetes mellitus; HDL = high-density lipoprotein; GFR = glomerular filtration rate; MI = myocardial infarction.